| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/NMETH1006-777 |
| P698 | PubMed publication ID | 16990807 |
| P50 | author | Julian Downward | Q6307119 |
| Jan Ellenberg | Q1296661 | ||
| Frank Buchholz | Q1443007 | ||
| David M. Sabatini | Q16231524 | ||
| René Bernards | Q20518809 | ||
| Michael Boutros | Q73877448 | ||
| William C Hahn | Q88192808 | ||
| David E Root | Q89000283 | ||
| Buzz Baum | Q30505213 | ||
| Andrew G. Fraser | Q37391371 | ||
| Norbert Perrimon | Q38523404 | ||
| Aimee L. Jackson | Q41626706 | ||
| Nir Hacohen | Q42799920 | ||
| Amy Kiger | Q61162550 | ||
| P2093 | author name string | Jussi Taipale | |
| Sumit K Chanda | |||
| Philip A Beachy | |||
| Peter S Linsley | |||
| Lawrence Lum | |||
| Yong Ma | |||
| Bernard Mathey-Prévôt | |||
| Christophe J Echeverri | |||
| P2860 | cites work | siRNAs can function as miRNAs | Q29615070 |
| Expression profiling reveals off-target gene regulation by RNAi | Q29615965 | ||
| Evidence of off-target effects associated with long dsRNAs in Drosophila melanogaster cell-based assays | Q33257000 | ||
| 3' UTR seed matches, but not overall identity, are associated with RNAi off-targets | Q34496075 | ||
| Enhancing and confirming the specificity of RNAi experiments | Q36575386 | ||
| Prevalence of off-target effects in Drosophila RNA interference screens | Q40233605 | ||
| High-throughput RNAi screening in cultured cells: a user's guide. | Q52666716 | ||
| P433 | issue | 10 | |
| P304 | page(s) | 777-779 | |
| P577 | publication date | 2006-10-01 | |
| P1433 | published in | Nature Methods | Q680640 |
| P1476 | title | Minimizing the risk of reporting false positives in large-scale RNAi screens | |
| P478 | volume | 3 |
| Q35696798 | A Genome-wide CRISPR Screen in Primary Immune Cells to Dissect Regulatory Networks |
| Q36161184 | A Guide to Genome-Wide In Vivo RNAi Applications in Drosophila. |
| Q42075805 | A High-Content RNAi Screen Identifies Ubiquitin Modifiers That Regulate TNF-Dependent Nuclear Accumulation of NF-κB. |
| Q35212807 | A Potential of microRNAs for High-Content Screening |
| Q37233401 | A Twist-Snail axis critical for TrkB-induced epithelial-mesenchymal transition-like transformation, anoikis resistance, and metastasis |
| Q33300789 | A case study of the reproducibility of transcriptional reporter cell-based RNAi screens in Drosophila |
| Q33521273 | A direct phenotypic comparison of siRNA pools and multiple individual duplexes in a functional assay |
| Q39167973 | A gene trap mutagenesis screen for genes underlying cellular response to the mood stabilizer lithium |
| Q39150492 | A genetic screen identifies TCF3/E2A and TRIAP1 as pathway-specific regulators of the cellular response to p53 activation. |
| Q36881106 | A genetic screen identifies interferon-α effector genes required to suppress hepatitis C virus replication |
| Q28487036 | A genetic screen using the PiggyBac transposon in haploid cells identifies Parp1 as a mediator of olaparib toxicity |
| Q34093403 | A genome wide RNA interference screening method to identify host factors that modulate influenza A virus replication |
| Q24655808 | A genome-wide RNAi screen for modifiers of the circadian clock in human cells |
| Q39374283 | A genome-wide RNAi screen identifies novel targets of neratinib resistance leading to identification of potential drug resistant genetic markers. |
| Q28257071 | A genome-wide RNAi screen reveals multiple regulators of caspase activation |
| Q27489773 | A genome-wide genetic screen for host factors required for hepatitis C virus propagation |
| Q34057896 | A genome-wide small interfering RNA screen identifies host factors required for vesicular stomatitis virus infection |
| Q21562478 | A large scale shRNA barcode screen identifies the circadian clock component ARNTL as putative regulator of the p53 tumor suppressor pathway |
| Q89693432 | A large-scale resource for tissue-specific CRISPR mutagenesis in Drosophila |
| Q34778691 | A loss-of-function screen for phosphatases that regulate neurite outgrowth identifies PTPN12 as a negative regulator of TrkB tyrosine phosphorylation. |
| Q53157645 | A multiplexed siRNA screening strategy to identify genes in the PARP pathway. |
| Q30377704 | A novel method for tissue-specific RNAi rescue in Drosophila. |
| Q37047996 | A pipeline for the generation of shRNA transgenic mice |
| Q42353295 | A platform for reverse genetics in endothelial cells |
| Q43788702 | A probability-based approach for the analysis of large-scale RNAi screens. |
| Q33891584 | A protein network-guided screen for cell cycle regulators in Drosophila |
| Q81246968 | A protocol for designing siRNAs with high functionality and specificity |
| Q49720448 | A reversible haploid mouse embryonic stem cell biobank resource for functional genomics. |
| Q34338200 | A role for neuropilins in the interaction between Schwann cells and meningeal cells |
| Q38279200 | A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor |
| Q35440069 | ADP-ribosylation factor-like 4C (ARL4C), a novel ovarian cancer metastasis suppressor, identified by integrated genomics |
| Q34523383 | ATARiS: computational quantification of gene suppression phenotypes from multisample RNAi screens |
| Q39427098 | AURKA suppression induces DU145 apoptosis and sensitizes DU145 to docetaxel treatment |
| Q27339381 | Abasic pivot substitution harnesses target specificity of RNA interference |
| Q93685376 | Addendum |
| Q34103346 | An off-target nucleostemin RNAi inhibits growth in human glioblastoma-derived cancer stem cells |
| Q38708498 | Applications of CRISPR genome editing technology in drug target identification and validation |
| Q35598498 | Applications of high-throughput RNA interference screens to problems in cell and developmental biology |
| Q33533546 | Automated microscopy for high-content RNAi screening |
| Q90644794 | Autophagy and mTOR signaling during intervertebral disc aging and degeneration |
| Q35991327 | BAGEL: a computational framework for identifying essential genes from pooled library screens. |
| Q47071667 | Bruchpilot, a synaptic active zone protein for anesthesia-resistant memory. |
| Q34517408 | C911: A bench-level control for sequence specific siRNA off-target effects |
| Q28474150 | COPI complex is a regulator of lipid homeostasis |
| Q39576647 | COS-1 cells as packaging host for production of lentiviruses |
| Q62132626 | CRISPR Technology for Breast Cancer: Diagnostics, Modeling, and Therapy |
| Q38196778 | CRISPR-Cas system: a powerful tool for genome engineering |
| Q47547574 | CRISPR-Cas9 Genetic Analysis of Virus-Host Interactions |
| Q38822073 | CRISPR-Cas9 technology and its application in haematological disorders |
| Q93161786 | CRISPR-Cas9-based mutagenesis frequently provokes on-target mRNA misregulation |
| Q24320073 | CRK7 modifies the MAPK pathway and influences the response to endocrine therapy |
| Q61808028 | Canthin-6-One Accelerates Alpha-Synuclein Degradation by Enhancing UPS Activity: Drug Target Identification by CRISPR-Cas9 Whole Genome-Wide Screening Technology |
| Q98771604 | Cell Reprogramming With CRISPR/Cas9 Based Transcriptional Regulation Systems |
| Q28541855 | Cell type-specific functions of period genes revealed by novel adipocyte and hepatocyte circadian clock models |
| Q27305816 | Cell-based screening: extracting meaning from complex data |
| Q46559934 | Central delivery of Dicer-substrate siRNA: a direct application for pain research |
| Q37799220 | Chemotherapy and signaling: How can targeted therapies supercharge cytotoxic agents? |
| Q41914377 | Chromosome 20q amplification regulates in vitro response to Kinesin-5 inhibitor. |
| Q42049385 | Clustering phenotype populations by genome-wide RNAi and multiparametric imaging. |
| Q33348012 | Coexpression of Argonaute-2 enhances RNA interference toward perfect match binding sites |
| Q35208467 | Comparative RNAi screening identifies a conserved core metazoan actinome by phenotype. |
| Q37051213 | Comprehensive identification of host modulators of HIV-1 replication using multiple orthologous RNAi reagents |
| Q27309190 | Computer vision profiling of neurite outgrowth dynamics reveals spatiotemporal modularity of Rho GTPase signaling |
| Q30489491 | CtBPs promote cell survival through the maintenance of mitotic fidelity. |
| Q39995047 | Culture of Drosophila S2 cells and their use for RNAi-mediated loss-of-function studies and immunofluorescence microscopy |
| Q33754229 | DNA polymerases as potential therapeutic targets for cancers deficient in the DNA mismatch repair proteins MSH2 or MLH1 |
| Q33605316 | Design and evaluation of genome-wide libraries for RNA interference screens |
| Q33298809 | Design and implementation of high-throughput RNAi screens in cultured Drosophila cells |
| Q39345010 | Determination of synthetic lethal interactions in KRAS oncogene-dependent cancer cells reveals novel therapeutic targeting strategies |
| Q57279362 | Do-it-yourself RNAi made easy? |
| Q37900773 | Drosophila RNAi screening in a postgenomic world |
| Q38373756 | E-RNAi: a web application for the multi-species design of RNAi reagents--2010 update |
| Q42325936 | Efficient shRNA-mediated inhibition of gene expression in zebrafish |
| Q36412675 | Enhanced Functional Genomic Screening Identifies Novel Mediators of Dual Leucine Zipper Kinase-Dependent Injury Signaling in Neurons. |
| Q38706202 | Evaluation and Design of Genome-Wide CRISPR/SpCas9 Knockout Screens. |
| Q42777701 | Evaluation and control of miRNA-like off-target repression for RNA interference |
| Q48209699 | Evaluation of RNAi and CRISPR technologies by large-scale gene expression profiling in the Connectivity Map. |
| Q36911581 | Evidence for Osteocalcin Binding and Activation of GPRC6A in β-Cells |
| Q37008841 | Expanding the repertoire of RNA interference screens for developing new anticancer drug targets |
| Q30503223 | Factors affecting reproducibility between genome-scale siRNA-based screens |
| Q33798562 | False negative rates in Drosophila cell-based RNAi screens: a case study |
| Q42113424 | FatJ acts via the Hippo mediator Yap1 to restrict the size of neural progenitor cell pools |
| Q48747209 | Functional Genomic Characterization of Cancer Genomes |
| Q38782688 | Functional Genomic Strategies for Elucidating Human-Virus Interactions: Will CRISPR Knockout RNAi and Haploid Cells? |
| Q35096493 | Functional genetics for all: engineered nucleases, CRISPR and the gene editing revolution |
| Q26858957 | Functional genomic and high-content screening for target discovery and deconvolution |
| Q21562253 | G protein-coupled receptor kinase 2 promotes flaviviridae entry and replication |
| Q57170220 | Gene editing in the context of an increasingly complex genome |
| Q33899105 | Genes associated with prognosis after surgery for malignant pleural mesothelioma promote tumor cell survival in vitro |
| Q36508693 | Genetic analysis of hyl-1, the C. elegans homolog of LAG1/LASS1. |
| Q43046092 | Genetic interactions: the missing links for a better understanding of cancer susceptibility, progression and treatment. |
| Q27694704 | Genetic screens and functional genomics using CRISPR/Cas9 technology |
| Q29617411 | Genetic screens in human cells using the CRISPR-Cas9 system |
| Q84957547 | Genome-Wide CRISPR Screen Identifies Host Factors Required by Infection |
| Q38647442 | Genome-Wide RNAi Screens for RNA Processing Events in Drosophila melanogaster S2 Cells |
| Q35780370 | Genome-Wide Screening of Genes Required for Glycosylphosphatidylinositol Biosynthesis |
| Q90054175 | Genome-scale CRISPR knockout screen identifies TIGAR as a modifier of PARP inhibitor sensitivity |
| Q36040827 | Genome-scale CRISPR pooled screens |
| Q29616044 | Genome-scale CRISPR-Cas9 knockout screening in human cells |
| Q30836392 | Genome-scale RNAi profiling of cell division in human tissue culture cells |
| Q91619371 | Genome-wide CRISPR screen identifies ELP5 as a determinant of gemcitabine sensitivity in gallbladder cancer |
| Q39390952 | Genome-wide RNA interference analysis of renal carcinoma survival regulators identifies MCT4 as a Warburg effect metabolic target |
| Q34000149 | Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo |
| Q35779181 | Genome-wide functional screen identifies a compendium of genes affecting sensitivity to tamoxifen |
| Q39241612 | GenomeCRISPR - a database for high-throughput CRISPR/Cas9 screens. |
| Q33265010 | GenomeRNAi: a database for cell-based RNAi phenotypes |
| Q24626537 | Genomic screening with RNAi: results and challenges |
| Q29616375 | Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication |
| Q24336198 | Haploid genetic screens in human cells identify host factors used by pathogens |
| Q27692612 | Hidden reach of the micromanagers. |
| Q34619274 | High-content siRNA screening for target identification and validation |
| Q39615752 | High-throughput RNAi screening in mammalian cells with esiRNAs |
| Q45023402 | High-throughput small interfering RNA screens: when small interfering RNAs behave like microRNA |
| Q97418728 | Humanized GPRC6AKGKY is a gain-of-function polymorphism in mice |
| Q34042815 | Identification and functional clustering of genes regulating muscle protein degradation from amongst the known C. elegans muscle mutants |
| Q24309649 | Identification of CDK10 as an important determinant of resistance to endocrine therapy for breast cancer |
| Q34525720 | Identification of Drosophila gene products required for phagocytosis of Leishmania donovani |
| Q28473657 | Identification of Drosophila mitotic genes by combining co-expression analysis and RNA interference |
| Q33347345 | Identification of JAK/STAT pathway regulators--insights from RNAi screens |
| Q24706780 | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics |
| Q37775134 | Identifying HIV-1 host cell factors by genome-scale RNAi screening. |
| Q37938872 | Illuminating the gateway of gene silencing: perspective of RNA interference technology in clinical therapeutics. |
| Q37186412 | Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy |
| Q37590429 | In Vivo RNAi-Based Screens: Studies in Model Organisms |
| Q36736715 | In vivo RNAi screens: concepts and applications |
| Q33294992 | Increasing the robustness and validity of RNAi screens |
| Q37146658 | Junctional adhesion molecule A interacts with Afadin and PDZ-GEF2 to activate Rap1A, regulate beta1 integrin levels, and enhance cell migration |
| Q99238002 | Key Mechanistic Principles and Considerations Concerning RNA Interference |
| Q33383241 | Kinome-wide RNAi screen implicates at least 5 host hepatocyte kinases in Plasmodium sporozoite infection |
| Q47209937 | Link synthetic lethality to drug sensitivity of cancer cells |
| Q37600610 | Loss-of-function genetic screens as a tool to improve the diagnosis and treatment of cancer |
| Q33577868 | MISSION esiRNA for RNAi screening in mammalian cells |
| Q38978817 | Measuring error rates in genomic perturbation screens: gold standards for human functional genomics |
| Q39300457 | Methods for High-Throughput RNAi Screening in Drosophila Cells. |
| Q39895165 | MicroRNA-like off-target transcript regulation by siRNAs is species specific. |
| Q34224360 | MicroRNA-mediated myostatin silencing in caprine fetal fibroblasts |
| Q28471588 | Mining predicted essential genes of Brugia malayi for nematode drug targets |
| Q26824514 | Mitochondrial targets for pharmacological intervention in human disease |
| Q36840172 | Modeling oncogene addiction using RNA interference. |
| Q43100594 | Molecular biology. Use and abuse of RNAi to study mammalian gene function |
| Q35702911 | Morphological Profiles of RNAi-Induced Gene Knockdown Are Highly Reproducible but Dominated by Seed Effects |
| Q30437106 | Multiparametric analysis of focal adhesion formation by RNAi-mediated gene knockdown |
| Q41665683 | NLK is a novel therapeutic target for PTEN deficient tumour cells |
| Q60301188 | Network-Guided Discovery of Influenza Virus Replication Host Factors |
| Q33584524 | Networks and pathways in pigmentation, health, and disease |
| Q37325819 | Neurogenetics of courtship and mating in Drosophila |
| Q52430564 | New tools for old drugs: Functional genetic screens to optimize current chemotherapy. |
| Q27024576 | Nodal expression and detection in cancer: experience and challenges |
| Q63246311 | OR14I1 is a receptor for the human cytomegalovirus pentameric complex and defines viral epithelial cell tropism |
| Q52726519 | Off and back-on again: a tumor suppressor's tale. |
| Q28914776 | Off-target effects dominate a large-scale RNAi screen for modulators of the TGF-β pathway and reveal microRNA regulation of TGFBR2 |
| Q33346459 | Off-target effects of siRNA specific for GFP |
| Q37154915 | P21 gene knock down does not identify genetic effectors seen with gene knock out. |
| Q39883994 | PDGF/VEGF signaling controls cell size in Drosophila |
| Q47595090 | PICKLES: the database of pooled in-vitro CRISPR knockout library essentiality screens. |
| Q80391527 | PTPome-wide functional RNA interference screening methods |
| Q39876330 | Parallel RNAi screens across different cell lines identify generic and cell type-specific regulators of actin organization and cell morphology |
| Q38904862 | Phenotypic screening with primary neurons to identify drug targets for regeneration and degeneration. |
| Q34325450 | Posterior association networks and functional modules inferred from rich phenotypes of gene perturbations |
| Q36286492 | Properties of short double-stranded RNAs carrying randomized base pairs: toward better controls for RNAi experiments |
| Q33605413 | Protein interaction network topology uncovers melanogenesis regulatory network components within functional genomics datasets |
| Q36226039 | Proteomic and functional genomic landscape of receptor tyrosine kinase and ras to extracellular signal-regulated kinase signaling |
| Q38618624 | Proteomics in the genome engineering era. |
| Q52430521 | RNA Interference (RNAi) Screening in Drosophila. |
| Q37954953 | RNA interference in Caenorhabditis elegans: uptake, mechanism, and regulation |
| Q33397910 | RNA interference screening demystified |
| Q34995323 | RNA interference screening for the discovery of oncology targets |
| Q27025675 | RNA-guided CRISPR-Cas technologies for genome-scale investigation of disease processes |
| Q40145783 | RNASEK Is a V-ATPase-Associated Factor Required for Endocytosis and the Replication of Rhinovirus, Influenza A Virus, and Dengue Virus. |
| Q24303918 | RNAi screen indicates widespread biological function for human natural antisense transcripts |
| Q28654521 | RNAi screening comes of age: improved techniques and complementary approaches |
| Q34029015 | RNAi screening identifies HAT1 as a potential drug target in esophageal squamous cell carcinoma |
| Q34386075 | RNAi screening in Drosophila cells and in vivo. |
| Q35571345 | RNAi screening reveals requirement for host cell secretory pathway in infection by diverse families of negative-strand RNA viruses. |
| Q34033373 | RNAi screening: new approaches, understandings, and organisms |
| Q34564130 | RNAi screening: tips and techniques |
| Q56688678 | RNAi technologies: a screen whose time has arrived |
| Q33867432 | RNAi-based screening identifies kinases interfering with dioxin-mediated up-regulation of CYP1A1 activity |
| Q37378480 | RNAi-mediated knockdown showing impaired cell survival in Drosophila wing imaginal disc. |
| Q37157043 | Rapid assessment of RNAi-mediated protein depletion by selected reaction monitoring mass spectrometry |
| Q37440284 | Rapid creation and quantitative monitoring of high coverage shRNA libraries |
| Q37665303 | Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application |
| Q36255190 | Recombinase-based conditional and reversible gene regulation via XTR alleles |
| Q24289530 | Reproducibility of results in preclinical studies: a perspective from the bone field |
| Q47676897 | Requirement of glycosylation machinery in Toll-like receptor responses revealed by CRISPR/Cas9 screening |
| Q30847567 | Revealing molecular mechanisms by integrating high-dimensional functional screens with protein interaction data |
| Q94461819 | Role of GPRC6A in Regulating Hepatic Energy Metabolism in Mice |
| Q39632893 | Role of MSK1 in the Malignant Phenotype of Ras-transformed Mouse Fibroblasts |
| Q92744806 | SGLT1 is required for the survival of triple-negative breast cancer cells via potentiation of EGFR activity |
| Q35042352 | SIRT1 is highly expressed in brain metastasis tissues of non-small cell lung cancer (NSCLC) and in positive regulation of NSCLC cell migration |
| Q30485759 | Scoring diverse cellular morphologies in image-based screens with iterative feedback and machine learning |
| Q28601274 | ScreenBEAM: a novel meta-analysis algorithm for functional genomics screens via Bayesian hierarchical modeling |
| Q30671092 | ScreenSifter: analysis and visualization of RNAi screening data |
| Q89848771 | Screening Genes Promoting Exit from Naive Pluripotency Based on Genome-Scale CRISPR-Cas9 Knockout |
| Q38676328 | Seed-effect modeling improves the consistency of genome-wide loss-of-function screens and identifies synthetic lethal vulnerabilities in cancer cells |
| Q43638969 | Selective elimination/RNAi silencing of FMRF-related peptides and their receptors decreases the locomotor activity in Drosophila melanogaster |
| Q21245112 | Selective gene silencing by viral delivery of short hairpin RNA |
| Q34243538 | Shortcomings of short hairpin RNA-based transgenic RNA interference in mouse oocytes |
| Q33357070 | Single cell cytometry of protein function in RNAi treated cells and in native populations |
| Q26752417 | Small Non-coding RNAs Associated with Viral Infectious Diseases of Veterinary Importance: Potential Clinical Applications |
| Q33284309 | Small interfering RNA profiling reveals key role of clathrin-mediated endocytosis and early endosome formation for infection by respiratory syncytial virus |
| Q38014586 | Small interfering ribonucleic acid design strategies for effective targeting and gene silencing. |
| Q36073459 | Sources of Error in Mammalian Genetic Screens. |
| Q24644919 | Statistical methods for analysis of high-throughput RNA interference screens |
| Q33408769 | Steroid hormone control of cell death and cell survival: molecular insights using RNAi |
| Q61799297 | Structural rearrangements generate cell-specific, gene-independent CRISPR-Cas9 loss of fitness effects |
| Q38348127 | Studying circadian rhythm and sleep using genetic screens in Drosophila |
| Q37950261 | Subcellular fate and off-target effects of siRNA, shRNA, and miRNA. |
| Q36379543 | Synthetic lethality of PARP and NAMPT inhibition in triple-negative breast cancer cells |
| Q21267232 | Systematic analysis of off-target effects in an RNAi screen reveals microRNAs affecting sensitivity to TRAIL-induced apoptosis |
| Q33766729 | Systematic discovery of mutation-specific synthetic lethals by mining pan-cancer human primary tumor data. |
| Q51913883 | Systems survey of endocytosis by multiparametric image analysis. |
| Q35261541 | Systems-biology approaches to discover anti-viral effectors of the human innate immune response |
| Q36242919 | TRIM25 Enhances the Antiviral Action of Zinc-Finger Antiviral Protein (ZAP). |
| Q34647792 | Targeting CDH17 suppresses tumor progression in gastric cancer by downregulating Wnt/β-catenin signaling |
| Q35216621 | The FLIGHT Drosophila RNAi database: 2010 update |
| Q37180850 | The art and design of genetic screens: RNA interference. |
| Q38836751 | The big bang of genome editing technology: development and application of the CRISPR/Cas9 system in disease animal models |
| Q24295243 | The corepressor CTBP2 is a coactivator of retinoic acid receptor/retinoid X receptor in retinoic acid signaling |
| Q33316626 | The current status of cDNA cloning |
| Q34042999 | The histone demethylase Jarid1b (Kdm5b) is a novel component of the Rb pathway and associates with E2f-target genes in MEFs during senescence |
| Q33701404 | The lncRNA VELUCT strongly regulates viability of lung cancer cells despite its extremely low abundance. |
| Q28505001 | The protein dendrite arborization and synapse maturation 1 (Dasm-1) is dispensable for dendrite arborization |
| Q37478081 | Towards better mouse models: enhanced genotypes, systemic phenotyping and envirotype modelling |
| Q37890867 | Towards systematic functional characterization of cancer genomes |
| Q50925712 | Transforming growth factor β1 (TGFβ1) regulates CD44V6 expression and activity through extracellular signal-regulated kinase (ERK)-induced EGR1 in pulmonary fibrogenic fibroblasts. |
| Q38907081 | Two members of the TRiC chaperonin complex, CCT2 and TCP1 are essential for survival of breast cancer cells and are linked to driving oncogenes |
| Q33931946 | Using functional genetics to understand breast cancer biology |
| Q36864047 | Utilizing RNA interference to enhance cancer drug discovery |
| Q35836004 | Vigilance and validation: Keys to success in RNAi screening |
| Q37540874 | What have RNAi screens taught us about viral-host interactions? |
| Q39358611 | Whole genome in vivo RNAi screening identifies the leukemia inhibitory factor receptor as a novel breast tumor suppressor |
| Q24313063 | ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcome |
| Q35452056 | cSSMD: assessing collective activity for addressing off-target effects in genome-scale RNA interference screens. |
| Q35800841 | gespeR: a statistical model for deconvoluting off-target-confounded RNA interference screens |
| Q35992666 | siRNA off-target effects in genome-wide screens identify signaling pathway members |
| Q39091684 | siRNA screen for genes that affect Junín virus entry uncovers voltage-gated calcium channels as a therapeutic target |
| Q30578753 | siRNA screen of ES cell-derived motor neurons identifies novel regulators of tetanus toxin and neurotrophin receptor trafficking |
| Q42134712 | Φ-score: A cell-to-cell phenotypic scoring method for sensitive and selective hit discovery in cell-based assays. |
Search more.